"use strict";(self.webpackChunkgatsby_starter_hello_world=self.webpackChunkgatsby_starter_hello_world||[]).push([[581],{2673:function(e,t,a){a.r(t);var n=a(7294),i=a(5984),r=a(1508),l=a(6089),o=a(2658),s=a(2116),p=a(9941),c=a(7425),m=a(5092),d=a(1079),x=a(6571),g=a(4345),f=a(8032);(0,g.Z)({typography:{fontSize:{xl:18,lg:18,md:18,sm:16,xs:16}}});t.default=()=>{const e=["Protocol","Baseline Report","Updated Reports","Evidence Surveillance","See in L.OVE"],t=["Updated Report","See in L.OVE"];return n.createElement(i.Z,null,n.createElement(r.Z,{sx:{marginTop:"20px",height:"100%"}},n.createElement(r.Z,{sx:{background:"#fff"}},n.createElement(l.Z,{sx:{height:{xs:"25px",sm:"25px",md:"50px"}}}),n.createElement(l.Z,{sx:{display:"flex"}},n.createElement(r.Z,{sx:{display:{xs:"none",sm:"block"},marginRight:"10px"}},n.createElement(f.S,{src:"../assets/images/simple-logo-lgreen.png",alt:"bkg",height:100,placeholder:"tracedSVG",layout:"constrained",__imageData:a(1273)})),n.createElement(o.Z,{variant:"h3",sx:{fontSize:{xl:50,lg:50,md:50,sm:40,xs:25},display:"flex",justifyContent:{xs:"center",sm:"initial"},alignItems:"center",width:"100%"}},"LE-Synthesis Repository")),n.createElement(l.Z,{sx:{height:"50px"}})),n.createElement(l.Z,{sx:{padding:"0px 0px !important"}},n.createElement(o.Z,{variant:"body1",sx:{fontSize:{xl:20,lg:20,md:20,sm:16,xs:16},fontFamily:"calibri",marginTop:"-30px",paddingTop:{xl:"40px",lg:"40px",md:"40px",sm:"20px",xs:"20px"},paddingX:{xl:"40px",lg:"40px",md:"40px",sm:"20px",xs:"20px"},border:"2px",borderRadius:"50px",backgroundClip:"border-box",background:"white"},gutterBottom:!0},"LE-IHD program has supported the development of several living guidelines from various organisations. With this free access repository, we support the evidence ecosystem by avoiding duplication of efforts between groups and we support the reuse of evidence in the processes of generation and adaptation of recommendations. The shared documents are registered in the Open Science Framework, and its citation must include the corresponding doi."),n.createElement(s.Z,{variant:"middle",sx:{marginY:"40px",marginX:"100px",background:"#99CC33",height:"2px"}}),n.createElement(r.Z,{sx:{position:"relative",fontSize:{xl:18,lg:18,md:18,sm:16,xs:16},paddingX:{xl:"40px",lg:"40px",md:"40px",sm:"20px",xs:"20px"},paddingBottom:{xl:"40px",lg:"40px",md:"40px",sm:"20px",xs:"20px"},border:"2px",borderRadius:"50px",backgroundClip:"border-box",marginBottom:"-30px",background:"white",zIndex:1e3}},n.createElement(l.Z,{sx:{display:"flex"}},n.createElement(o.Z,{variant:"h3",sx:{fontSize:{xl:32,lg:32,md:32,sm:30,xs:26},display:"flex",justifyContent:"center",alignItems:"center",width:"100%"}},"Ongoing")),n.createElement(p.Z,{sx:{display:"none"}},n.createElement(c.Z,null),n.createElement(m.Z,null)),["Effectiveness and safety of deep brain stimulation in severe and resistant Obsessive Compulsive Disorder","Genicular artery embolization in patients with knee pain secondary to osteoarthritis refractory to usual care","Effectiveness and safety of non-hospital cardiac rehabilitation (primary care, community, home) in patients with ischemic heart disease or heart failure","Cytoreductive surgery (CRS) giving together with hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric patients (<14 or 18 years) with peritoneal carcinomatosis","Phophylaxis with vitamin D compared to placebo or no prophilaxis In patients at risk of SARS-Cov-2 infection or with mild, moderate or severe COVID-19.","Hyperbaric oxygen therapy In patients with persistent COVID 19","Biologic therapy (monoclonal antibodies) be given in combination with other interventions (LABA/LAMA; ICS, pulmonary rehabilitation) in adults with COPD","Glucagon-like peptide analogues and agonists in type II diabetes","Bevacizumab, Olaparib, Rucaparib and Niraparib for ovarian cancer ","Combined therapy vs monotherapy in treatment of hypertension in adults with diabetes"].map((t=>n.createElement(p.Z,{disableGutters:!0,sx:{background:"#fff",marginY:"20px"}},n.createElement(c.Z,{expandIcon:n.createElement(x.Z,null),"aria-controls":"panel2a-content",id:"panel2a-header"},n.createElement(o.Z,{variant:"body1",sx:{fontFamily:"calibri",fontSize:{xl:24,lg:24,md:24,sm:18,xs:18}},gutterBottom:!0},t)),n.createElement(m.Z,null,e.map(((e,t)=>n.createElement(o.Z,{variant:"body1",sx:{fontFamily:"calibri",fontSize:{xl:22,lg:22,md:22,sm:16,xs:16}},gutterBottom:!0},n.createElement(d.Z,{fontWeight:"bold",href:"",target:"_blank",underline:"",color:"black"},e)))))))),n.createElement(p.Z,{sx:{display:"none"}},n.createElement(c.Z,null),n.createElement(m.Z,null))),n.createElement(s.Z,{variant:"middle",sx:{marginY:"40px",marginX:"100px",background:"#99CC33",height:"2px"}}),n.createElement(r.Z,{sx:{position:"relative",fontSize:{xl:18,lg:18,md:18,sm:16,xs:16},paddingX:{xl:"40px",lg:"40px",md:"40px",sm:"20px",xs:"20px"},paddingBottom:{xl:"40px",lg:"40px",md:"40px",sm:"20px",xs:"20px"},border:"2px",borderRadius:"50px",backgroundClip:"border-box",marginBottom:"-30px",background:"white",zIndex:1e3}},n.createElement(l.Z,{sx:{display:"flex"}},n.createElement(o.Z,{variant:"h3",sx:{fontSize:{xl:32,lg:32,md:32,sm:30,xs:26},display:"flex",justifyContent:"center",alignItems:"center",width:"100%"}},"Resolved")),n.createElement(p.Z,{sx:{display:"none"}},n.createElement(c.Z,null),n.createElement(m.Z,null)),["Chimeric antigen receptor T cell therapy for hematological malignancies","Fecal microbiota transplant for ulcerative colitis ","Mechanical assist devices in cardiovascular diseases","Glucagon-like peptide analogues and agonists in type II diabetes mellitus","Three-dimensional mammography for breast cancer","Bevacizumab, olaparib, rucaparib and niraparib for ovarian cancer"].map((e=>n.createElement(p.Z,{disableGutters:!0,sx:{background:"#fff",marginY:"20px"}},n.createElement(c.Z,{expandIcon:n.createElement(x.Z,null),"aria-controls":"panel2a-content",id:"panel2a-header"},n.createElement(o.Z,{variant:"body1",sx:{fontFamily:"calibri",fontSize:{xl:24,lg:24,md:24,sm:18,xs:18}},gutterBottom:!0},e)),n.createElement(m.Z,null,t.map(((e,t)=>n.createElement(o.Z,{variant:"body1",sx:{fontFamily:"calibri",fontSize:{xl:22,lg:22,md:22,sm:16,xs:16}},gutterBottom:!0},n.createElement(d.Z,{fontWeight:"bold",href:"",target:"_blank",underline:"",color:"black"},e)))))))),n.createElement(p.Z,{sx:{display:"none"}},n.createElement(c.Z,null),n.createElement(m.Z,null)))),n.createElement(r.Z,{sx:{background:"#fff"}},n.createElement(l.Z,{sx:{height:"50px"}}))))}},1273:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#98c838","images":{"fallback":{"src":"/static/a5e7c36f014025f7560ae0278e4e5ed7/15e42/simple-logo-lgreen.png","srcSet":"/static/a5e7c36f014025f7560ae0278e4e5ed7/88208/simple-logo-lgreen.png 25w,\\n/static/a5e7c36f014025f7560ae0278e4e5ed7/e9fba/simple-logo-lgreen.png 50w,\\n/static/a5e7c36f014025f7560ae0278e4e5ed7/15e42/simple-logo-lgreen.png 100w,\\n/static/a5e7c36f014025f7560ae0278e4e5ed7/5aead/simple-logo-lgreen.png 200w","sizes":"(min-width: 100px) 100px, 100vw"},"sources":[{"srcSet":"/static/a5e7c36f014025f7560ae0278e4e5ed7/2fa99/simple-logo-lgreen.webp 25w,\\n/static/a5e7c36f014025f7560ae0278e4e5ed7/dbc4a/simple-logo-lgreen.webp 50w,\\n/static/a5e7c36f014025f7560ae0278e4e5ed7/d8057/simple-logo-lgreen.webp 100w,\\n/static/a5e7c36f014025f7560ae0278e4e5ed7/2e34e/simple-logo-lgreen.webp 200w","type":"image/webp","sizes":"(min-width: 100px) 100px, 100vw"}]},"width":100,"height":100}')}}]);
//# sourceMappingURL=component---src-pages-lesrepo-js-fbab5b3adf3678d0e8e8.js.map